SENSITIVE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ASSAY FOR PRAZIQUANTEL IN PLASMA, URINE AND LIVER HOMOGENATES

被引:15
作者
GONZALEZESQUIVEL, DF [1 ]
OKUNO, CM [1 ]
RODRIGUEZ, MS [1 ]
MORALES, JS [1 ]
COOK, HJ [1 ]
机构
[1] NATL INST NEUROL & NEUROSURG,NEUROPHARMACOL & NEUROIMMUNOL LABS,MEXICO CITY,MEXICO
来源
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS | 1993年 / 613卷 / 01期
关键词
D O I
10.1016/0378-4347(93)80213-N
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
A high-performance liquid chromatographic method for the determination of praziquantel in plasma, urine and rat liver homogenates has been developed. It requires 2 ml of biological fluid, an extraction using Sep-Pak cartridges, a 0.05 M phosphate buffer solution (pH 5.0) for equilibrating and washing and ethyl acetate-diisopropyl ether for drug elution. The analysis was performed on an Ultrasphere ODS C18 column with a mobile phase of acetonitrile-water with ultraviolet detection at 217 nm. The results showed that the assay is sensitive (31.2 ng/ml), linear between 0.125 and 4.0 mug/ml, precise (coefficient of variation = 10%) and selective with other drugs currently administered with praziquantel.
引用
收藏
页码:174 / 178
页数:5
相关论文
共 18 条
[1]   METABOLISM STUDIES OF THE ANTISCHISTOSOMAL DRUG PRAZIQUANTEL USING TANDEM MASS-SPECTROMETRY - QUALITATIVE IDENTIFICATION OF 17 HYDROXYLATED METABOLITES FROM MOUSE URINE [J].
ALI, MH ;
FETTEROLF, DD ;
ABRAMSON, FP ;
COHN, VH .
BIOMEDICAL AND ENVIRONMENTAL MASS SPECTROMETRY, 1990, 19 (03) :179-185
[2]  
Andrews P., 1976, Veterinary Medical Review, P154
[3]  
DIEKMANN HW, 1979, EUR J DRUG METAB PH, V3, P139
[4]  
FROHBERG H, 1981, ARZNEIMITTEL-FORSCH, V31-1, P555
[5]  
GROLL E, 1980, ACTA TROP, V37, P293
[6]  
Jung H, 1991, Proc West Pharmacol Soc, V34, P335
[7]   PHARMACOKINETICS OF PRAZIQUANTEL IN HEALTHY-VOLUNTEERS AND PATIENTS WITH SCHISTOSOMIASIS [J].
MANDOUR, MEM ;
ELTURABI, H ;
HOMEIDA, MMA ;
ELSADIG, T ;
ALI, HM ;
BENNETT, JL ;
LEAHEY, WJ ;
HARRON, DWG .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1990, 84 (03) :389-393
[8]  
OMER AHS, 1981, ARZNEIMITTELFORSCH, V31-1, P605
[9]  
Patzschke K, 1979, Eur J Drug Metab Pharmacokinet, V4, P149
[10]  
PUTTER LA, 1979, EUR J DRUG METAB PH, V3, P143